1. Homepage
  2. Equities
  3. Sweden
  4. NORDIC GROWTH MARKET
  5. SyntheticMR AB (publ)
  6. Summary
    SYNT   SE0015987946

SYNTHETICMR AB (PUBL)

(SYNT)
  Report
End-of-day quote NORDIC GROWTH MARKET  -  2022-08-09
39.50 SEK   +3.13%
07/13SyntheticMR's quantitative MRI solution SyMRI NEURO compatible with Philips SmartSpeed to support shorter scan times
AQ
07/13SyntheticMR's Quantitative MRI Solution Symri Neuro Compatible with Philips Smartspeed to Support Shorter Scan Times
CI
07/05Dr. Jeff Miller of Phoenix Children's Joins SyntheticMR's Medical Advisory Board
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Nordic Growth Market
08/04/2022 08/05/2022 08/08/2022 08/09/2022 08/10/2022 Date
38.5 38.7 39.3 38.3 39.5 Last
18159 19753 2623 1675 3205 Volume
+4.05% +0.52% +1.55% -2.54% +3.13% Change
Estimated financial data (e)
Sales 2022 68,7 M 6,85 M 6,85 M
Net income 2022 10,0 M 1,00 M 1,00 M
Net cash position 2022 77,0 M 7,68 M 7,68 M
P/E ratio 2022 165x
Yield 2022 -
Sales 2023 101 M 10,0 M 10,0 M
Net income 2023 29,0 M 2,89 M 2,89 M
Net cash position 2023 92,0 M 9,17 M 9,17 M
P/E ratio 2023 56,4x
Yield 2023 0,51%
Capitalization 1 645 M 164 M 164 M
EV / Sales 2022 22,8x
EV / Sales 2023 15,4x
Nbr of Employees 27
Free-Float 100%
More Financials
Company
SyntheticMR AB (publ) is a Sweden-based company that develops and markets software solutions for Magnetic Resonance Imaging (MRI). The Company provides SyMRI, which measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single MR scan. The SyMRI product is available in different packages. SyMRI IMAGE provides fast MRI... 
More about the company
Ratings of SyntheticMR AB (publ)
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D
More Ratings
All news about SYNTHETICMR AB (PUBL)
07/13SyntheticMR's quantitative MRI solution SyMRI NEURO compatible with Philips SmartSpeed ..
AQ
07/13SyntheticMR's Quantitative MRI Solution Symri Neuro Compatible with Philips Smartspeed ..
CI
07/05Dr. Jeff Miller of Phoenix Children's Joins SyntheticMR's Medical Advisory Board
AQ
07/05Dr. Jeff Miller Joins SyntheticMR's Medical Advisory Board
CI
07/05SYNTHETICMR : Dr. Jeff Miller of Phoenix Children's Joins SyntheticMR's Medical Advisory B..
PU
06/30SyntheticMR announces new subsidiary in India
AQ
06/30Syntheticmr AB Announces New Subsidiary in India
CI
05/30SyMRI MSK from SyntheticMR is now available on syngo.via Open Apps from Siemens Healthi..
AQ
05/30SyMRI MSK from SyntheticMR is Now Available on syngo.via Open Apps from Siemens Healthi..
CI
05/10Report from Annual General Meeting in SyntheticMR AB (publ)
AQ
05/10Interim report January - March 2022
AQ
05/10SyntheticMR AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/08Notice to attend the annual general meeting of SyntheticMR AB (publ)
AQ
04/08SyntheticMR publishes annual report for 2021
AQ
04/05SyntheticMR announces estimated net sales for the first quarter 2022 due to delays in c..
AQ
More news
News in other languages on SYNTHETICMR AB (PUBL)
07/13Symri Neuro, la solution d'IRM quantitative de SyntheticMR, est compatible avec Philips..
07/05Le Dr Jeff Miller rejoint le conseil consultatif médical de SyntheticMR
06/30Syntheticmr AB (Publ) annonce une nouvelle filiale en Inde
05/30SyMRI MSK de SyntheticMR est maintenant disponible sur syngo.via Open Apps de Siemens H..
05/10SyntheticMR AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2..
More news
Chart SYNTHETICMR AB (PUBL)
Duration : Period :
SyntheticMR AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 39,50 SEK
Average target price 45,00 SEK
Spread / Average Target 13,9%
EPS Revisions
Managers and Directors
Ulrik Harrysson Chief Executive Officer
Kyle Frye President & Chief Commercial Officer
Johanna Norén CFO & Head-Investor Relations
Johan Sedihn Chairman
Markus Malmgren Chief Technology Officer, Head-R&D
Sector and Competitors
1st jan.Capi. (M$)
SYNTHETICMR AB (PUBL)-36.29%164
VEEVA SYSTEMS INC.-13.09%35 319
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED-29.44%7 747
OMNICELL, INC.-41.68%4 754
PRO MEDICUS LIMITED-13.92%3 916
SECTRA AB (PUBL)-10.24%3 468